Article

Cleveland Clinic finds AMD animal model

A Cleveland Clinic research team has developed the first animal model of age-related macular degeneration (AMD), and it is expected to enable researchers to study the development and progression of AMD and conduct pre-clinical testing of new therapeutics.

Cleveland-A Cleveland Clinic research team has developed the first animal model of age-related macular degeneration (AMD), and it is expected to enable researchers to study the development and progression of AMD and conduct pre-clinical testing of new therapeutics.

The research team, led by Joe G. Hollyfield, PhD, of the institution's Cole Eye Institute, modified specific proteins found in mouse blood so that the mouse's immune system was forced to mount a response. This response causes the mouse to display characteristics of AMD in a short amount of time.

Specifically, Dr. Hollyfield and his team immunized mice with mouse serum albumin adducted with oxidation fragments of the long-chain fatty acid known as docosahexaenoic acid. Earlier studies by this group found that the fragments were localized in drusen from donor eye tissues and in plasma samples from patients with AMD. The immunized mice develop antibodies to the oxidation fragment, deposit complement in the outer eye wall, accumulate drusen below the retinal pigment epithelium, and show features of geographic atrophy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.